SEQUA.BR - SEQUANA MEDICAL
€1.48 0.03 (2.07%)
Updated: 08:21 May 9, 2024 ESTNext Session's AI Forecast
94.57%
Avg. Accuracy (AI)
€1.51
Next Week's AI Forecast
0%
Trend's Accuracy (AI)
€1.28
| Rank (0-100) |
| Rank (0-100) |
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0.43 | -0.06 | -1.38 | -0.61 | -0.35 |
|---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 1.29 | 1.59 | 3.54 | 4.61 | 3.68 |
|---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
| Curr. Week | Next Week | Curr. Month | Curr. Quarter | 100% | 100% | 90.91% | 5.85% |
|---|
MOVING AVERAGE METRIC
| 5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | % | % | % |
|---|
RSI METRIC
| RS Hour | RSI Hour | RS Day | RSI Day |
|---|
SEQUANA MEDICAL Technical Analysis News
SEQUANA MEDICAL
Kortrijksesteenweg 1112
box 102 Sint-Denijs-Westrem
Ghent 9051
Belgium
32 9 298 28 28
https://www.sequanamedical.com
| Sectors: | Healthcare |
| Industry: | Medical Devices |
| F. Time Employees: | 62 |
Description
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
Corporate Governance
Sequana Medical NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.